SCHEMBL6320557

SCHEMBL6320557

O=C(O)CCC(=O)NCc1ccc(N/C(=C2\C(=O)Nc3ccccc32)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.46
HTT P42858 2/20 0.43
ALDH1A1 P00352 2/20 0.43
PDE5A O76074 1/20 0.42
POLB P06746 4/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
PTPN1 P18031 1/20 0.39
RORC P51449 1/20 0.38
KDR P35968 1/20 0.38
GAA P10253 1/20 0.38
ITGB3 P05106 1/20 0.37
ITGAV P06756 1/20 0.37
CASP2 P42575 1/20 0.37
CASP7 P55210 1/20 0.37
CASP6 P55212 1/20 0.37
CASP8 Q14790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6320563 1.00 CASP3 (0.46) CASP3HTTALDH1A1PDE5APOLB
Hydrochloric Acid SCHEMBL6327305 0.88 AKT2 (0.45) CASP3POLBMEN1KMT2APTPN1
Hydrochloric Acid SCHEMBL6327307 0.88 AKT2 (0.45) CASP3POLBMEN1KMT2APTPN1
SCHEMBL6328124 0.86 PTPN1 (0.49) ALDH1A1POLBMEN1KMT2APTPN1
SCHEMBL6328129 0.86 PTPN1 (0.49) ALDH1A1POLBMEN1KMT2APTPN1
SCHEMBL6319510 0.86 PTPN1 (0.40) CASP3ALDH1A1MEN1KMT2APTPN1
SCHEMBL6320268 0.86 PTPN1 (0.40) CASP3ALDH1A1MEN1KMT2APTPN1
SCHEMBL6324728 0.86 L3MBTL1 (0.42) CASP3HTTALDH1A1MEN1KMT2A
SCHEMBL6324724 0.86 L3MBTL1 (0.42) CASP3HTTALDH1A1MEN1KMT2A
SCHEMBL6327927 0.84 NR1H4 (0.45) ALDH1A1POLBMEN1KMT2ARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6855710-B2 Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-02-15 US disclosed
US-20040058978-A1 Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-03-25 US disclosed
EP-1115704-B1 NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058978-A1 Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs CDK1, CDK2, CDK3 CASP3 1939/4885HTT 4696/4885ALDH1A1 1810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.